Serum FGF21 and RBP4 levels in patients with chronic hepatitis C

High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis

(2011) Salvatore Petta et al.   DIGESTIVE AND LIVER DISEASE

Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients

(2010) Pere Domingo et al.   AIDS

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease

(2010) Yusuf Yilmaz et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease

(2010) Jody Dushay et al.   GASTROENTEROLOGY

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

(2010) Huating Li et al.   JOURNAL OF HEPATOLOGY

Serum chemerin and vaspin in non-alcoholic fatty liver disease

(2010) Michal Kukla et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance

(2009) A. O. Chavez et al.   DIABETES CARE

Adipokines in liver diseases

(2009) Fabio Marra et al.   HEPATOLOGY

Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels

(2009) M. Iwasa et al.   JOURNAL OF VIRAL HEPATITIS

Visfatin serum levels in chronic hepatitis C patients

(2009) M. Kukla et al.   JOURNAL OF VIRAL HEPATITIS

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity

(2008) M. Mraz et al.   CLINICAL ENDOCRINOLOGY

Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis

(2008) Matthias J. Bahr et al.   CLINICAL ENDOCRINOLOGY

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

(2008) X. Zhang et al.   DIABETES

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

(2008) J. Xu et al.   DIABETES

Retinol‐binding protein 4: A new marker of virus‐induced steatosis in patients infected with hepatitis c virus genotype 1

(2008) Salvatore Petta et al.   HEPATOLOGY

Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C

(2008) Jee-Fu Huang et al.   JOURNAL OF HEPATOLOGY

Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

(2007) Haiya Wu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE